|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A multiple-dose, open-label, safety, compliance, and usage evaluation study of epicutaneously applied Diractin (ketoprofen in Transfersome) in joint/musculoskeletal pain or soft tissue inflammation 显示文摘 | KNEER W ROTHER I ROTHER M | 2009 | Curr Drug Saf2009，4，1： | 1 |
| 2 | Interacting epidemics? Sleep curtailment,insulin resistance,and obesity显示文摘 | Lucassen E A Rother K I Cizza G | 2012 | Ann N YAcad Sci2012，1264，1： | 1 |
| 3 | Role of insulin receptors and IGF receptors in growth and development显示文摘 | Rother K I Accili D | 2000 | Pediatr Nephrol2000，14，7： | 1 |
| 4 | Role of insulin receptors and IGF receptors in growth and development 显示文摘 | ROTHER K I ACCILI D | 2000 | Pe- diatric Nephrology2000，14，7： | 1 |
| 5 | Effects of exenatide alone and in combination with daclizumab on beta-cell function in long- standing type 1 diabetes显示文摘 | Rother K I Spain L M Wesley R A | 2009 | Diabetes Care2009，32，12： | 1 |
| 6 | The potential of building integrated (BIPV) and building applied photovoltaics (BAPV) in single-family, urban residences at low lati- tudes in Brazil 显示文摘 | SANTOS I P D ROTHER R | 2012 | Energy and Buildings2012，50，： | 1 |
| 7 | GRIMM : The GFZ Reference Internal Magnetic Model based on vector satellite and observatory data 显示文摘 | LESUR V WARDINSKI I ROTHER M | 2008 | Geophys J Int2008，173，： | 1 |
| 8 | Role of insulin receptors and IGF receptors in growth and development 显示文摘 | Rother K I Accili D | 2000 | Pediat- ric Nephrology2000，14，7： | 1 |
| 9 | Sucralose, a synthetic organochlorine sweetener:overview of biological issues显示文摘 | SCHIFFMAN S S ROTHER K I | 2013 | Journal of Toxicology and Environmental Health Part B:Critical Reviews2013，16，7： | 1 |
| 10 | 2010, International geomagnetic re显示文摘 | Finlay C C Maus S Beggan C D Bondar T D Chambodut A Chernova T A Chulliat A Golovkov V P Hamilton B Hamoudi M Holme R Hi]lot G Kuang W Langlais B Lesur V Lowes F J Luhr H Macmillan S Mandea M Mclean S Manoj C Menvielle M Michaelis I Olsen N Rauberg J Rother M Sabaka T J Tangborn A W P Toffner-Clausen L Thfibault E Thomson A Wardinski I Wei Z Zvereva T | 2010 | Geophys J Int2010，183，3： | 1 |
| 11 | Anatomic basis of micturation and urinary continence显示文摘 | Rother P Dorschner W Reibiger I | 1996 | Surg Radio1996，18，3： | 1 |
| 12 | Cortisol binding globulin: more than just a carrier显示文摘 | Cizza G Rother K I | 2012 | J Clin Endocrinol Metab2012，97，1： | 1 |
| 13 | Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory,and the historical archive 显示文摘 | Dynkevich Y Rother KI Whitford I | 2013 | Endocr Rev2013，34，6： | 1 |
| 14 | Role of insulin receptors and IGF receptors in growth and development 显示文摘 | Rother K I Accili D | 2000 | Pediatr Nephrol2000，14，7： | 1 |
| 15 | Effects of ex- enatide alone and in combination with daclizumab on beta - cell function in long - standing type 1 diabetes 显示文摘 | ROTHER K I SPAIN L M WESLEY R A | 2009 | Diabetes Care2009，32，12： | 1 |
| 16 | Possible adverse effects of SGLT2 inhibitors on bone显示文摘 | Simeon I Taylor Jenny E Blau Kristina I Rother | 2015 | The Lancet Diabetes & Endocrinology2015，，1： | 1 |
| 17 | Buddy Study: Partners for better health in adolescents with type 2 diabetes显示文摘AIM: To investigate whether assigning young, healthy and motivated lay volunteer partners('buddies') to adolescents with type 2 diabetes improves hemoglobin A1c(HbA 1c). METHODS: Adolescents with type 2 diabetes were randomized to partnering with a 'buddy' or to conventional treatment. During the initial screening visit, which coincided with a routine outpatient diabetes clinic visit, patients with type 2 diabetes underwent a physical examination, detailed medical history, laboratory measurement of HbA 1c, and completed two questionnaires(Pediatric Quality of Life Inventory and Children's Depression Inventory) to assess their overall quality of life and the presence of depressive symptoms. Patients were then randomized to the intervention(the buddy system) or conventional treatment(standard care). All patients were scheduled to return for followup at 3- and 6-mo after their initial visit. Hb A1 c was determined at all visits(i.e., at screening and at the 3- and 6-mo follow-up visits) and quality of life and depressive symptoms were evaluated at the screening visit and were reassessed at the 6-mo visit. RESULTS: Ten adolescents, recruited from a pool of approximately 200 adolescents, enrolled over a twoyear time period, leading to premature termination of the study. In contrast, we easily recruited motivated lay volunteers. We found no change in HbA 1c from the initial to the 6-mo visit in either group, yet our small sample size limited systematic assessment of this outcome. Participants repeatedly missed clinic appointments, failed to conduct self-glucose-monitoring and rarely brought their glucometers to clinic visits. Total quality of life scores(72.6 ± 6.06) at screening were similar to previously reported scores in adolescents with type 2 diabetes(75.7 ± 15.0) and lower than scores reported in normal-weight(81.2 ± 0.9), overweight(83.5 ± 1.8), and obese youths without diabetes(78.5 ± 1.8) or in adolescents with type 1 diabetes(80.5 ± 13.1). Among adolescents who returned for their 6-mo visit, there were no differences in total quality of life scores(70.2 ± 9.18) between screening and follow-up.CONCLUSION: Our approach, effective in adults with type 2 diabetes, was unsuccessful among adolescents and emphasizes the need for innovative strategies for diabetes treatment in adolescent patients. | Allison C Sylvetsky Radha Nandagopal Tammy T Nguyen Marisa R Abegg Mahathi Nagarur Paul Kaplowitz Kristina I Rother | 2015 | World Journal of Diabetes2015，6，18： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员